Felix Dobbs, Broken String Biosciences CEO

Ex­clu­sive: Backed by Il­lu­mi­na, Bro­ken String Bio­sciences rais­es $15M to find off-tar­get gene ed­its

Bro­ken String Bio­sciences has raised $15 mil­lion for its off-tar­get se­quenc­ing ser­vice for gene edit­ing com­pa­nies.

The Se­ries A round was led by Il­lu­mi­na Ven­tures …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.